Supplementary Figure S6 from Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Fig.S6: The purified expanded PBNK cells have higher activating receptors expression PBNK cells were expanded ex vivo by co-culturing PBMC with irradiated geK562 feeder cell lines in the presence of 40 U/mL IL-2 for 14 days and isolated by depleting CD3+ T cells. NK cells were stained with indicated monoclonal antibodies immediately after isolation. Cell surface expression on viable cells is shown by flow cytometry analysis.
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362532084